Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Jin Yang Pharmaceutical Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Jin Yang Pharmaceutical has a total shareholder equity of ₩92.9B and total debt of ₩18.2B, which brings its debt-to-equity ratio to 19.6%. Its total assets and total liabilities are ₩131.0B and ₩38.1B respectively. Jin Yang Pharmaceutical's EBIT is ₩6.5B making its interest coverage ratio 6.1. It has cash and short-term investments of ₩4.1B.
Anahtar bilgiler
19.6%
Borç/özkaynak oranı
₩18.22b
Borç
| Faiz karşılama oranı | 6.1x |
| Nakit | ₩4.14b |
| Eşitlik | ₩92.86b |
| Toplam yükümlülükler | ₩38.14b |
| Toplam varlıklar | ₩130.99b |
Son finansal sağlık güncellemeleri
These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well
Aug 12
These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Safely
Feb 11
Recent updates
Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370) Shares Fly 32% But Investors Aren't Buying For Growth
Aug 19These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well
Aug 12Jin Yang Pharmaceutical's (KOSDAQ:007370) Problems Go Beyond Weak Profit
May 23A Look At The Intrinsic Value Of Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
Mar 22Here's Why I Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is An Interesting Stock
Mar 04These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Safely
Feb 11Are Jin Yang Pharmaceutical Co., Ltd.'s (KOSDAQ:007370) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Jan 21Does Jin Yang Pharmaceutical's (KOSDAQ:007370) Share Price Gain of 49% Match Its Business Performance?
Jan 04We're Not So Sure You Should Rely on Jin Yang Pharmaceutical's (KOSDAQ:007370) Statutory Earnings
Dec 17Here's Why We Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is Well Worth Watching
Nov 30Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: A007370's short term assets (₩44.3B) exceed its short term liabilities (₩32.1B).
Uzun Vadeli Yükümlülükler: A007370's short term assets (₩44.3B) exceed its long term liabilities (₩6.0B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: A007370's net debt to equity ratio (15.2%) is considered satisfactory.
Borcun Azaltılması: A007370's debt to equity ratio has reduced from 35% to 19.6% over the past 5 years.
Borç Kapsamı: A007370 şirketinin borcu operating nakit flow ( 70.3% ) tarafından iyi bir şekilde karşılanıyor.
Faiz Kapsamı: A007370's interest payments on its debt are well covered by EBIT (6.1x coverage).